Centessa Pharmaceuticals (CNTA) Leases (2023 - 2026)
Centessa Pharmaceuticals (CNTA) reported Leases of $9.8 million for Q1 2026, down 9.13% year-over-year from $10.8 million in Q1 2025, and down 2.52% on a QoQ basis from $10.0 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 4 years of Leases data on file, last reported at $9.8 million in Q1 2026.
- Quarterly Leases fell 9.13% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 9.13% YoY) and the FY2025 annual result came in at $10.0 million, down 8.77% from the prior year.
- Leases eased to $9.8 million in Q1 2026 per CNTA's latest filing, from $10.0 million in the prior quarter.
- Across five years, Leases topped out at $12.3 million in Q1 2023 and bottomed at $9.8 million in Q1 2026.
- The 4-year median for Leases is $11.2 million (2024), against an average of $11.2 million.
- The widest annual swing landed in 2024, when Leases retreated 4.93%; it then fell 9.13% in 2026.
- Tracing CNTA's Leases over 4 years: stood at $11.9 million in 2023, then slipped by 7.56% to $11.0 million in 2024, then declined by 8.77% to $10.0 million in 2025, then declined by 2.52% to $9.8 million in 2026.
- Per Business Quant, the three latest CNTA Leases figures stand at $9.8 million (Q1 2026), $10.0 million (Q4 2025), and $10.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 9.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.79 Mn |
| Dec 31, 2025 | 10.05 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | 10.78 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Sep 30, 2024 | 11.24 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 12.13 Mn |
| Jun 30, 2023 | 12.30 Mn |
| Mar 31, 2023 | 12.30 Mn |